≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Brain, supratentorial

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_BRAIN_SUPRATENT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D33.0
  • Cause of death: ICD-10 — D33.0

2 out of 7 registries used, show all original rules.

587

4. Check minimum number of events

None

587

5. Include endpoints

None

587

6. Filter based on genotype QC (FinnGen only)

587

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D33
Name in latin
Neoplasma benignum cerebri supratentoriale

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4145 2224 1899
Only index persons 3782 2059 1723
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.05
Only index persons 0.07 0.08 0.07
Median age at first event (years)
Whole population 49.48 51.35 47.25
Only index persons 48.74 50.53 46.61

-FinnGen-

Key figures

All Female Male
Number of individuals 587 339 248
Unadjusted period prevalence (%) 0.11 0.12 0.11
Median age at first event (years) 50.38 46.72 55.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
533
Matched controls
5327
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
220.3
217.7
213
16
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
202.3
181
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
25.3
179.2
271
209
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
135.3
124
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
94.6
88
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
63.1
81.5
94
18
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
13.7
75.9
139
134
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
73.7
69
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
60.3
70.6
82
16
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.4
67.4
152
216
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
60.6
57
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
17.8
59.3
95
64
N03AF02
ATC
oxcarbazepine; oral
15.2
54.5
93
73
D33.30
ICD-10 Finland
Acoustic neuroma
77.8
50.1
56
8
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
23.1
47.6
69
34
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
110.1
46.6
50
5
AA1AD
NOMESCO Finland
CT of head and brain
4.3
46.5
220
746
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
57.4
44.5
52
10
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
20.7
44.0
66
36
N03AX14
ATC
levetiracetam; systemic
14.9
43.4
74
57
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
41.8
42.8
53
14
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
17.0
40.4
65
43
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
17.3
39.4
63
41
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
38.0
36
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
75.6
37.5
42
6
ZXC95
NOMESCO Finland
Use of surgical navigator
30.1
35.3
47
17
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.7
32.9
62
59
XA800
NOMESCO Finland
Neuropsychological investigation
8.5
30.4
69
92
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
23.3
27.4
39
18
R51.80
ICD-10 Finland
Headache
3.6
26.8
138
467
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.7
26.0
69
116
N03AG01
ATC
valproic acid; systemic, rectal
6.2
25.7
72
130
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
15.6
25.6
42
29
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.4
25.4
142
510
D33.04
ICD-10 Finland
Temporal lobe
+∞
25.2
24
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
58.9
24.3
28
5
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
24.1
23
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
250.6
23.8
24
*
H53.4
ICD-10 Finland
Visual field defects
14.9
23.5
39
28
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
23.1
22
*
H02AB02
ATC
dexamethasone; systemic
4.2
22.8
94
259
XCK00
NOMESCO Finland
Perimetry
4.9
22.2
77
178
N03AB02
ATC
phenytoin; systemic
24.3
21.5
30
13
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
24.3
21.5
30
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
21.5
133
506
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
29.4
21.1
28
10
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
80.0
20.8
23
*
N03AF01
ATC
carbamazepine; oral, rectal
6.1
20.8
58
104
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
218.0
20.7
21
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
14.6
19.8
33
24
183
Kela drug reimbursment
Lamotrigin and topiramate
23.6
19.2
27
12
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
54.5
18.1
21
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
17.8
17
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
21.8
16.1
23
11
G93.0
ICD-10 Finland
Cerebral cysts
34.5
15.8
20
6
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
29.6
15.3
20
7
N03AX18
ATC
lacosamide; systemic
14.7
14.7
24
17
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
82.4
14.6
16
*
H02AB09
ATC
hydrocortisone; systemic
7.9
14.6
33
44
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
153.9
14.5
15
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.8
14.1
62
179
N88
ICPC
Epilepsy
30.9
14.0
18
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
13.8
100
414
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
77.1
13.6
15
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
13.3
13.5
23
18
N76
ICPC
Neoplasm nervous system unspecified
143.4
13.5
14
*
E23.00
ICD-10 Finland
Panhypopituitarism
41.2
13.2
16
*
WX882
NOMESCO Finland
High dependency care
5.5
13.1
39
76
L01AX03
ATC
temozolomide; systemic
17.2
13.1
20
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
12.9
71
242
Z2445
NOMESCO Finland
Psychologist
4.4
12.6
46
112
2152
FHL
Extraction, big brain
71.6
12.6
14
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
71.6
12.6
14
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
32.9
12.6
16
5
D32.03
ICD-10 Finland
Benign meningioma in ventricles
132.9
12.5
13
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
27.4
12.1
16
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
12.0
167
953
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
47.8
11.9
14
*
G40.10
ICD-10 Finland
Simple partial seizures
16.9
11.7
18
11
N05BA09
ATC
clobazam; oral
14.0
11.5
19
14
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.1
11.5
65
228
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
11.5
11
*
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
11.5
11
*
N75
ICPC
Benign neoplasm nervous system
+∞
11.5
11
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
11.5
11
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.3
11.4
59
195
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
9.2
11.4
23
26
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
13.1
11.2
19
15
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
25.6
11.2
15
6
TAB00
NOMESCO Finland
Lumbar puncture
4.4
11.1
40
97
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.5
11.1
28
45
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
44.3
11.0
13
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
28.7
10.8
14
5
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
61.2
10.7
12
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
61.2
10.7
12
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
10.4
10
*
R42
ICD-10 Finland
Dizziness and giddiness
2.1
10.1
123
654
H53.2
ICD-10 Finland
Diplopia
5.5
10.1
29
55
G40
ICD-10 Finland
Epilepsy
14.9
10.0
16
11
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
40.9
10.0
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.2
9.9
114
592
G91.0
ICD-10 Finland
Communicating hydrocephalus
26.6
9.8
13
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
9.7
52
176
N03AX09
ATC
lamotrigine; oral
4.0
9.7
38
100
101
Kela drug reimbursment
Anterior pituitary hypofunction
13.7
9.7
16
12
AAF00
NOMESCO Finland
Ventriculostomy
13.7
9.7
16
12
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
101.7
9.4
10
*
H02.2
ICD-10 Finland
Lagophthalmos
101.7
9.4
10
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
101.7
9.4
10
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
9.4
9
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
9.4
9
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
+∞
9.4
9
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
9.4
9
*
ZXC40
NOMESCO Finland
Use of ultrasound
11.7
9.1
16
14
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
11.7
9.1
16
14
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
14.3
8.7
14
10
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
50.8
8.7
10
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.8
8.6
15
13
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
8.5
207
1406
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
20.4
8.5
12
6
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
91.4
8.4
9
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
91.4
8.4
9
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.6
8.4
28
64
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
8.3
8
*
N05AX08
ATC
risperidone; systemic
2.9
8.3
49
179
ZXC86
NOMESCO Finland
Use of endoscopic device
14.8
8.2
13
9
H47.2
ICD-10 Finland
Optic atrophy
17.5
8.1
12
7
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
33.9
8.1
10
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
33.9
8.1
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
8.1
193
1301
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
22.4
8.0
11
5
R4110
NOMESCO Finland
Physiotherapy
1.9
8.0
146
902
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
8.0
42
142
R51
ICD-10 Finland
Headache
3.3
8.0
39
125
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
15.3
7.7
12
8
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
45.6
7.7
9
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
45.6
7.7
9
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
45.6
7.7
9
*
G44.2
ICD-10 Finland
Tension-type headache
2.3
7.7
76
365
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
81.1
7.4
8
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
7.4
55
230
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.1
7.3
13
12
D33.11
ICD-10 Finland
Brain stem
+∞
7.3
7
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
7.3
7
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
7.3
7
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
20.3
7.2
10
5
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.2
7.1
12
10
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
10.2
7.1
13
13
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.1
7.0
16
23
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
6.0
7.0
18
31
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
6.6
58
265
WF002
NOMESCO Finland
Radical radiotherapy
3.3
6.5
31
98
ZZC00
NOMESCO Finland
Graft of fascia
70.6
6.4
7
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
70.6
6.4
7
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
70.6
6.4
7
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
70.6
6.4
7
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
70.6
6.4
7
*
Z3231
NOMESCO Finland
Registered nurse
1.7
6.4
147
967
AA1AA
NOMESCO Finland
Head X-ray examination
18.3
6.3
9
5
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
6.3
6
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.3
6
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
+∞
6.3
6
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
6.2
75
395
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.2
114
698
N03AX11
ATC
topiramate; oral
4.0
6.1
23
60
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
6.1
80
435
WF099
NOMESCO Finland
Other radiotherapy
12.7
6.1
10
8
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.8
6.1
14
21
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
47
38
13.36
48.36
1.3
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
146
470
3.80
38.99
6.8
8.6
mmol/l
1.4
1.3
0.17
105
379
(3027801) Oxygen [Partial pressure] in Arterial blood
145
470
3.77
38.28
6.8
8.5
kpa
15.9
12.7
5.61
135
456
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
145
470
3.77
38.28
6.8
8.5
kpa
5.1
5.1
0.39
136
453
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
38
39
10.35
33.31
2.5
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
357
2191
2.61
27.70
7.5
6.8
mmol/l
1.2
1.2
1.85
335
1855
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
22
12.82
27.40
1.8
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
331
1982
2.54
26.72
7.0
6.1
mmol/l
1.2
1.2
4.42
313
1805
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
52
108
5.19
24.11
2.2
1.6
e6/l
16.2
11.9
0.16
44
86
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
52
108
5.19
24.11
2.3
1.7
e6/l
2750.9
149.2
0.79
44
89
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
51
108
5.08
23.12
2.0
1.6
mmol/l
3.5
3.7
0.41
46
99
(3044290) Cell count panel - Cerebral spinal fluid
48
99
5.19
22.41
2.3
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
31
42
7.74
21.82
1.9
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
230
1328
2.20
18.21
2.6
2.0
u/l
273.7
233.9
0.14
222
1254
(3036481) Cortisol [Moles/volume] in Serum or Plasma
106
448
2.67
16.81
3.4
1.9
nmol/l
302.6
368.6
2.85
97
412
(4035726)
94
388
2.69
15.56
1.2
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
376
2716
2.07
15.55
6.3
4.8
mmol/l
6.4
6.6
1.63
360
2515
(3019060) Gas panel - Arterial blood
72
258
3.04
15.47
6.7
6.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
114
533
2.41
14.50
7.0
6.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
51
5.29
12.79
2.1
2.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
130
677
2.18
12.70
2.3
2.1
s
28.1
29.7
3.99
130
662
(3020891) Body temperature
51
168
3.23
12.59
4.6
4.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
30
69
4.53
12.29
5.2
4.8
umol/l
373.7
384.9
0.14
25
61
(3033658) Prothrombin time (PT) actual/Normal
189
1155
1.94
11.81
3.7
3.8
%
94.4
91.9
0.82
183
1132
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
30
6.51
11.61
1.1
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
216
1446
1.78
9.74
2.3
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
175
1109
1.82
9.43
2.3
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
297
2190
1.72
9.42
3.7
3.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
52
4.15
7.86
1.0
1.1
—
—
—
0
0
(4027681)
15
28
5.47
7.76
1.1
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
21
54
4.00
7.49
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
253
1867
1.62
7.45
2.4
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
159
1050
1.71
7.16
4.7
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
118
717
1.81
7.09
1.8
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
251
1871
1.60
6.95
4.9
4.6
g/l
35.6
36.1
0.67
234
1746
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
156
2.61
6.83
2.6
1.4
u/l
7.7
9.5
0.31
30
123
(3008295) Osmolality of Serum or Plasma
19
49
3.97
6.76
1.3
1.2
mosm/kgh2o
279.7
283.4
0.34
14
35
(3018418) pH of Serum or Plasma
187
1310
1.63
6.63
4.4
3.7
ph
7.4
7.4
1.16
21
245
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
430
3662
1.65
6.62
4.9
3.9
pmol/l
14.5
14.6
0.30
404
3317
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
29
4.92
6.48
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
236
1759
1.57
6.40
6.2
8.1
inr
1.1
1.2
0.50
59
535
(40761535) Cells panel - Urine sediment
70
371
2.01
6.35
4.6
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
342
2777
1.55
6.29
9.8
9.1
e9/l
4.3
4.0
0.81
296
2442
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
5
18.25
6.28
1.4
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
302
2389
1.54
6.23
6.7
5.9
e9/l
0.6
0.6
0.32
258
2070
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
491
1.85
5.98
1.7
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
110
689
1.73
5.90
3.4
3.8
mmol/l
0.8
0.8
0.69
104
652
(3013115) Eosinophils [#/volume] in Blood
309
2476
1.52
5.88
6.8
6.2
e9/l
0.2
0.2
0.71
270
2188
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
84
486
1.85
5.87
1.7
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
45
3.86
5.85
1.1
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
301
2401
1.52
5.83
6.7
5.9
e9/l
0.0
0.0
0.29
257
2085
(3000991) Gas panel - Venous blood
68
368
1.96
5.81
8.3
8.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
308
2470
1.52
5.81
6.7
5.9
e9/l
1.8
2.0
1.44
265
2191
(3035637) Corticotropin [Mass/volume] in Plasma
19
55
3.54
5.77
1.7
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
222
1683
1.51
5.35
3.6
3.5
ng/l
49.1
34.7
0.46
152
1110
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
296
2383
1.49
5.30
6.7
6.1
umol/l
9.6
11.6
4.59
279
2254
(40758558) Short blood count panel - Blood
167
1196
1.55
5.20
6.4
6.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
37
169
2.27
4.92
1.3
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
413
3586
1.51
4.89
8.2
7.2
u/l
76.6
78.7
0.47
391
3360
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
211
2.12
4.81
11.5
12.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
179
1327
1.50
4.68
3.6
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
524
4840
1.77
4.46
17.7
12.8
mg/l
23.5
21.9
0.53
452
3774
(3015377) Calcium [Moles/volume] in Serum or Plasma
195
1487
1.47
4.39
2.9
3.2
mmol/l
2.3
2.4
1.35
164
1325
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
22
4.61
4.31
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
46
3.32
4.21
2.1
1.3
nmol/l
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
27
4.13
4.18
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
221
1749
1.42
4.00
2.1
1.9
pmol/l
93.7
95.6
0.24
108
930
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
59
2.94
3.93
2.5
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
87
574
1.61
3.79
6.1
5.7
mmol/l
1.0
1.0
0.02
77
533
(3019150) Specific gravity of Urine by Refractometry
142
1044
1.48
3.78
5.1
3.6
kg/l
1.0
1.0
0.42
22
134
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
238
1930
1.39
3.67
2.3
2.3
nmol/l
73.1
75.4
0.83
215
1733
(3013707) Erythrocyte sedimentation rate by Westergren method
398
3518
1.41
3.63
4.7
4.0
mm/h
10.9
11.1
0.14
372
3249
(3035320) C reactive protein [Mass/volume] in Body fluid
10
26
3.90
3.53
3.8
2.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
13
6.22
3.51
1.1
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
13
6.22
3.51
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
13
6.22
3.51
1.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
6
10.09
3.50
1.3
1.2
nmol/l
2.4
7.7
—
6
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
90
611
1.56
3.47
1.6
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
64
2.71
3.42
1.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
204
1628
1.39
3.41
3.9
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
241
1.85
3.37
2.4
1.4
iu/l
26.4
24.2
0.15
37
200
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
14
5.78
3.35
1.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
538
5075
1.72
3.33
16.4
11.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
199
1588
1.38
3.31
7.3
5.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
54
2.82
3.27
2.2
1.3
nmol/l
0.7
0.5
0.74
15
48
(3007853) Bacteria identified in Skin by Aerobe culture
80
536
1.57
3.27
1.7
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
15
5.39
3.20
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
15
5.39
3.20
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
139
1791
0.71
3.17
2.7
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
365
3217
1.36
3.15
3.7
3.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
20
4.55
3.12
1.7
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
80
543
1.55
3.10
17.5
19.2
inr
1.5
1.2
0.72
12
82
(4268621)
15
56
2.72
3.08
2.2
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
60
381
1.64
3.06
2.4
2.7
g/l
10.4
10.3
0.06
55
349
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
540
5117
1.69
3.04
12.2
9.8
u/l
27.4
26.5
0.45
527
4938
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
12
5.89
3.03
1.7
2.1
umol/l
26.5
17.7
—
7
12
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
51
2.79
3.00
2.2
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
260
2194
1.33
2.93
6.7
6.1
%
0.7
0.7
0.25
243
2062
(3019225) pH of Specimen
63
412
1.59
2.87
3.9
4.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
30
159
1.93
2.81
2.7
1.7
ug/l
1.7
3.7
0.47
23
138
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
18
4.49
2.80
1.1
1.1
umol/l
2.9
5.5
—
8
18
(3037522) Nuclear Ab [Titer] in Serum
93
666
1.47
2.80
1.3
1.3
titre
378.2
517.4
0.82
22
140
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
174
1.89
2.78
1.5
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
55
351
1.63
2.77
3.1
2.4
ug/l
7.0
6.4
0.11
49
314
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
476
4413
1.42
2.76
5.5
4.6
mu/l
2.0
2.1
0.22
440
4043
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.39
2.75
1.6
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
353
1.62
2.71
2.7
2.3
nmol/l
12.5
12.9
0.16
50
316
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
61
2.50
2.64
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
105
779
1.42
2.63
1.9
1.7
nmol/l
1101.4
1181.7
0.46
85
597
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
7
7.19
2.55
1.0
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
7
7.19
2.55
1.4
7.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
7
7.19
2.55
1.2
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
11
5.50
2.55
1.5
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
288
1.65
2.51
2.9
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
188
1.80
2.50
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
109
2.06
2.49
2.3
2.8
u/ml
0.4
0.3
—
9
60
(3037467) Urinalysis macro (dipstick) panel - Urine
362
3246
1.30
2.46
4.9
4.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
263
2263
1.29
2.45
6.7
6.0
%
2.7
2.8
0.36
247
2123
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
102
763
1.41
2.44
3.5
2.6
e6/l
1.5
0.9
0.77
66
433
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
117
2.01
2.43
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
174
1421
1.32
2.37
2.9
2.4
u/l
55.9
55.9
0.00
157
1318
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
8
6.29
2.37
1.6
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
147
1.88
2.37
1.6
1.5
iu/ml
0.1
0.0
—
9
27
(3009261) Glucose [Presence] in Urine by Test strip
274
2379
1.28
2.35
4.6
3.4
estimate
0.0
0.0
0.50
39
432
(3019069) Monocytes/100 leukocytes in Blood
263
2273
1.28
2.34
7.0
6.3
%
8.7
8.6
0.15
248
2145
(36304419) Bacteria [Presence] in Urine
153
1233
1.33
2.28
3.7
2.9
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
299
1.58
2.19
1.7
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
94
2.06
2.18
2.1
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
197
1653
1.29
2.17
4.1
3.6
e6/l
41.9
98.5
1.34
146
1163
(3029937) Albumin [Presence] in Urine by Test strip
156
1269
1.31
2.17
5.2
3.7
estimate
0.0
0.0
0.69
38
450
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
30
3.03
2.15
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
123
971
1.34
2.11
2.7
2.5
e6/l
4.0
5.9
1.00
111
850
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
254
1.62
2.10
1.8
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
89
2.05
2.08
1.9
1.4
nmol/l
0.2
0.3
0.61
12
70
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
103
793
1.36
2.08
2.9
2.7
mmol/l
2.4
2.4
1.76
89
703
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
10
5.03
2.07
1.0
1.1
—
—
—
0
0
(4306422)
15
69
2.20
2.06
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
20
3.53
2.06
1.0
1.1
miu/ml
1556.7
1338.0
—
7
20
(3035350) Ketones [Presence] in Urine by Test strip
266
2329
1.26
2.05
4.7
3.4
estimate
0.0
0.0
0.00
41
448
(3021601) Nitrite [Presence] in Urine by Test strip
268
2349
1.26
2.04
6.0
4.6
estimate
0.0
0.0
0.00
39
456
(3026782) Osmolality of Urine
116
914
1.34
2.01
3.0
2.7
mosm/kgh2o
559.8
562.9
0.05
100
778
(3018010) Neutrophils/100 leukocytes in Blood
264
2313
1.26
2.01
6.4
5.9
%
57.5
56.7
0.51
249
2183
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
32
2.84
2.00
1.0
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
58
406
1.48
1.99
4.6
4.6
mmol/l
2.1
1.7
0.40
50
326
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
468
0.60
1.96
1.7
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
280
0.49
1.95
1.4
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
266
2340
1.25
1.93
6.8
6.1
%
27.6
28.6
0.71
251
2202
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
317
0.52
1.92
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
189
1.68
1.91
1.6
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
560
5430
1.68
1.90
26.8
18.8
e12/l
4.5
4.5
1.00
555
5289
(40761536) Microorganisms panel - Urine sediment
25
415
0.58
1.89
5.0
3.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
22
3.21
1.88
1.3
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
320
1.51
1.85
2.9
3.8
kpa
5.0
5.1
0.34
41
304
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
389
1.46
1.81
1.6
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
1187
1.28
1.79
4.7
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
140
1154
1.28
1.74
2.8
2.1
mg/l
2.8
2.9
0.48
117
986
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
105
834
1.32
1.73
3.7
3.6
ng/l
80.2
274.4
2.26
73
607
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
24
2.94
1.72
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
243
1.56
1.72
3.1
4.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
326
1.48
1.71
1.5
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
82
1.98
1.71
1.3
1.2
u/ml
4.6
4.2
—
10
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
303
1.49
1.66
2.9
3.9
mmol/l
0.7
1.6
1.01
33
218
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
76
2.00
1.65
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
72
544
1.37
1.65
4.4
4.3
%
31.4
32.0
0.19
54
355
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
98
1.86
1.63
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
125
1025
1.28
1.62
1.6
1.5
nmol/l
20.2
20.5
0.07
107
869
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.4
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
14
3.59
1.62
1.4
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
14
3.59
1.62
1.4
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
354
3253
1.22
1.59
4.2
3.0
u/l
51.6
43.7
1.11
337
3067
(3028707) Methadone [Presence] in Urine by Screen method
20
114
1.78
1.58
4.5
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
72
550
1.35
1.55
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
43
0.00
1.52
0.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
530
0.68
1.50
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
187
1.58
1.48
3.7
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
141
1187
1.25
1.47
2.9
3.1
ng/l
738.3
1140.9
1.80
120
1014
(3030467) Casts [#/volume] in Urine by Automated count
149
1267
1.24
1.41
3.9
3.0
e6/l
0.3
0.3
0.30
122
948
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
183
1591
1.22
1.40
3.8
3.1
u/l
28.7
31.8
0.92
170
1523
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
29
2.43
1.39
3.7
2.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
411
1.37
1.37
1.8
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
159
1.60
1.37
1.8
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
37
0.00
1.35
0.0
1.3
—
30560.4
—
0
17
(3021589) Normoblasts [#/volume] in Blood
244
2188
1.20
1.34
9.4
9.1
e9/l
0.0
0.0
0.53
186
1794
(3023199) Leukocytes [#/volume] in Pleural fluid
0
39
0.00
1.34
0.0
1.3
—
1670.8
—
0
22
(3012441) Differential panel - Pleural fluid
0
40
0.00
1.33
0.0
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
162
1399
1.22
1.32
3.7
3.1
e6/l
39.1
93.0
0.55
136
1079
(3041096) Erythrocytes [Presence] in Urine by Automated
114
1355
0.80
1.31
4.0
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
468
4463
1.24
1.30
14.9
11.9
ml/min/173m2
86.5
84.4
1.17
402
3638
(3023520) Reticulocytes [#/volume] in Blood
47
346
1.39
1.29
2.8
2.9
e9/l
57.4
70.7
2.43
37
267
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
355
1.38
1.28
2.1
2.6
ml/min/173m2
70.9
69.6
0.07
14
149
(3001122) Ferritin [Mass/volume] in Serum or Plasma
240
2156
1.19
1.28
3.1
2.7
ug/l
106.0
105.6
0.01
217
2000
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
55
2.02
1.28
1.1
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
9
44
2.06
1.27
1.4
1.4
g/l
2.9
2.6
—
9
28
(4062490)
9
44
2.06
1.27
1.4
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
9
44
2.06
1.27
1.4
1.4
g/l
7.5
6.4
—
9
29
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.6
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
724
1.27
1.24
3.6
2.8
e6/l
2.0
2.4
0.29
54
398
(3002256) Pathology report gross observation
71
561
1.30
1.24
1.2
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
26
2.32
1.19
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
26
2.32
1.19
1.2
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
215
1.47
1.18
4.4
3.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
33
0.00
1.16
0.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
65
1.86
1.14
1.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
277
1.40
1.13
1.5
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
127
1.60
1.13
1.8
3.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
40
2.01
1.12
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
168
1.51
1.11
1.7
2.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
81
1.75
1.10
2.2
2.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
59
1.88
1.08
2.3
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
74
1.77
1.07
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
859
1.23
1.07
1.6
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
847
1.22
1.00
1.2
1.3
iu/ml
37.4
32.1
0.10
27
263
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
76
1.73
0.99
1.1
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.2
—
35.9
—
0
24
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
52
409
1.30
0.97
3.4
2.5
g/l
0.2
0.2
0.26
46
385
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
54
1.87
0.97
2.6
3.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
106
909
1.20
0.94
1.6
1.7
pmol/l
438.2
6570735.8
0.50
92
761
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.6
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
156
1387
1.17
0.91
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
324
1.32
0.91
4.9
3.9
ng/l
89.7
77.0
0.34
34
289
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
46
360
1.30
0.90
1.1
1.2
iu/ml
174.8
177.2
0.01
18
156
(40768797) Stomach Pathology biopsy report
75
626
1.23
0.87
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
30
2.01
0.87
1.7
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
133
1173
1.17
0.86
2.4
2.8
umol/l
331.5
6918.7
4.63
117
1025
(40767503) Oxygen content in Capillary blood by calculation
13
80
1.64
0.85
2.3
2.6
%
18.2
15.7
—
7
40
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
307
0.71
0.84
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
57
1.77
0.84
1.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
121
1.50
0.83
1.5
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
141
0.56
0.83
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
223
1.36
0.83
3.6
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
59
483
1.25
0.82
2.7
2.8
%
1.6
1.7
0.55
50
439
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
138
1.47
0.82
1.4
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
81
1.62
0.82
1.3
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
89
1.59
0.82
1.0
2.2
g/l
143.3
128.8
—
9
64
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
139
1.45
0.80
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
106
1.52
0.79
1.1
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.6
—
1.1
—
0
19
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
48
1.68
0.79
6.5
3.1
nmol/l
1.8
6.8
—
8
48
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
74
626
1.21
0.77
1.9
1.8
%
1.6
1.5
0.50
68
557
(3020630) Protein [Mass/volume] in Serum or Plasma
42
333
1.28
0.77
1.9
3.0
g/l
68.5
67.0
0.64
36
301
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
53
1.71
0.75
1.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
116
1.48
0.75
1.5
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
201
1846
1.14
0.74
5.1
3.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
108
1.49
0.74
1.5
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
38
1.85
0.73
4.7
2.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
136
0.58
0.73
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
136
0.58
0.73
1.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
119
1060
1.15
0.69
1.8
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
69
1.61
0.68
1.2
2.3
u/ml
3.0
62.2
0.50
11
63
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.9
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
42
1.67
0.68
1.4
1.2
—
79.0
—
0
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
118
1052
1.15
0.68
2.0
1.8
mg/l
1.4
1.2
0.29
90
803
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
43
1.64
0.67
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
43
1.64
0.67
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
43
1.64
0.67
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
277
1.28
0.67
2.1
2.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
86
1.52
0.66
3.5
3.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
178
0.67
0.65
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
62
1.62
0.65
1.4
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
166
0.66
0.65
2.3
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
207
1.32
0.65
3.0
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
279
1.27
0.64
1.5
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
104
1.45
0.63
1.2
1.2
—
11.9
—
0
7
(3027008) Opiates [Presence] in Urine
31
244
1.29
0.62
3.5
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
182
1.33
0.62
1.4
1.3
miu/ml
179.0
257.3
—
10
92
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
88
1.49
0.61
1.5
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
245
1.28
0.61
3.5
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
148
1.36
0.60
1.3
2.9
g/l
2.9
3.2
1.23
13
118
(3035933) Granulocytes/100 leukocytes in Blood
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
72
1.54
0.59
1.4
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
72
1.54
0.59
1.6
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
166
1.34
0.59
6.8
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
1.2
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
123
1112
1.13
0.58
5.0
4.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
158
1.34
0.58
1.3
2.8
g/l
3.7
3.8
0.05
13
117
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
158
1.34
0.58
1.3
2.8
g/l
7.4
7.5
0.15
14
122
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
158
1.34
0.58
1.3
2.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
132
1.38
0.57
1.2
1.2
—
2.8
—
0
16
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
115
1.40
0.57
1.6
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
55
1.46
0.56
1.9
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(4010399)
40
331
1.22
0.55
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
350
3363
1.10
0.53
3.1
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
243
1.25
0.50
3.6
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
41
1.47
0.50
2.0
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
144
1328
1.11
0.50
4.9
4.8
ug/l
4.0
2.3
0.64
128
1188
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
12.4
2.9
u/ml
29.3
51.6
—
7
45
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
46
1.53
0.48
1.1
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
166
0.72
0.48
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
166
0.72
0.48
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
166
0.72
0.48
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
166
0.72
0.48
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
102
1.38
0.47
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
41
482
0.84
0.47
1.3
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
255
1.23
0.46
2.1
2.6
e6/l
0.2
0.1
0.39
31
246
(40768800) Prostate Pathology biopsy report
5
82
0.61
0.46
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
79
707
1.14
0.45
3.1
2.2
umol/l
13.3
13.4
0.04
70
656
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
127
0.70
0.44
1.1
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
115
1057
1.11
0.43
4.6
4.3
%
22.6
21.2
0.59
65
483
(4024509)
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3036603) Volume of Urine
5
32
1.57
0.42
1.2
1.7
—
2118.0
—
0
5
(3042631) Mycobacterium sp identified in Specimen
8
58
1.38
0.41
1.6
2.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
33
1.52
0.41
1.2
1.9
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
2.4
—
0
10
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
63.4
—
0
9
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
97.5
—
0
15
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
13
172
0.75
0.41
3.8
3.2
u/ml
109.2
1741.7
0.93
13
147
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
5.6
—
29.5
—
0
5
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
104.8
—
0
11
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
465
4554
1.10
0.41
4.8
4.3
mmol/l
5.7
5.9
3.16
424
4164
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
150
1.28
0.40
6.2
5.2
mg/l
1.2
1.4
1.32
19
138
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
52
590
0.87
0.40
1.2
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
152
1422
1.09
0.40
4.4
3.2
mmol/l
8.1
7.8
0.30
132
1214
(3004616) Nuclear Ab [Presence] in Serum
8
60
1.34
0.40
1.6
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
35
1.43
0.39
4.6
2.4
e9/l
0.2
0.2
—
5
30
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
36
1.39
0.38
1.2
1.3
e6/l
2387.2
185000.8
—
5
25
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
36
1.39
0.38
4.6
2.3
e6/l
419.0
492.6
—
5
30
(3020961) Endomysium IgA Ab [Titer] in Serum
31
262
1.19
0.38
1.2
1.2
—
163.9
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
112
0.71
0.37
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
69
1.31
0.37
1.9
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
72
1.40
0.37
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
72
654
1.12
0.35
2.3
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
134
1256
1.09
0.34
3.4
3.3
mg/l
38.1
158.9
1.01
95
814
(3017732) Neutrophils [#/volume] in Blood
37
321
1.16
0.34
6.2
2.6
e9/l
3.6
4.1
0.72
27
264
(40760888) Immunoglobulin light chains.free panel - Serum
12
91
1.33
0.34
2.3
4.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
81
742
1.11
0.34
1.9
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
820
1.10
0.33
1.3
1.3
u/ml
4.3
11.9
1.29
35
325
(21494890) Protein electrophoresis panel - 24 hour Urine
6
46
1.31
0.33
2.2
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
99
0.70
0.31
1.0
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
53
1.32
0.31
2.7
1.8
%
91.2
90.0
—
7
53
(36660697) Celiac disease serology panel - Serum
44
391
1.14
0.31
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
430
0.88
0.30
4.0
2.4
u/l
33.7
31.0
0.15
31
363
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
93
1.30
0.30
2.1
1.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
148
1.22
0.29
2.1
1.8
nmol/l
36.3
38.4
0.16
18
142
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
307
1.15
0.29
2.9
3.0
ng/l
173.5
168.4
0.02
30
270
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
195
0.82
0.29
1.3
1.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
62
1.29
0.28
1.0
1.3
—
75.1
—
0
5
(3013512) EKG study
134
1269
1.07
0.27
3.8
3.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
243
1.16
0.27
3.8
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
77
1.30
0.26
1.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
197
1.17
0.26
1.3
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
217
1.16
0.25
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
77
1.17
0.24
1.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
115
1.22
0.23
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
147
0.81
0.23
1.3
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
88
1.25
0.22
3.7
3.2
e9/l
4.2
4.2
0.02
11
88
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
88
1.25
0.22
2.5
2.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
125
1.21
0.22
2.0
1.9
iu/l
2.0
7.0
—
6
38
(4146454)
5
40
1.25
0.22
3.6
2.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
135
0.81
0.22
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
556
1.09
0.22
1.7
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
40
363
1.11
0.22
4.3
4.7
%
0.0
0.1
2.61
13
104
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
10
0.00
0.21
0.0
1.7
—
1.2
—
0
10
(3002179) Metamyelocytes/100 leukocytes in Blood
39
354
1.11
0.21
3.7
4.6
%
0.6
0.4
—
10
82
(3003129) Base excess in Capillary blood by calculation
0
12
0.00
0.21
0.0
1.1
—
2.3
—
0
12
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
73
684
1.08
0.21
1.8
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
25.1
—
0
13
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
1.4
—
8.4
—
0
8
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
1.7
—
0
6
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
145
1.18
0.21
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
80
1.25
0.20
1.4
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
82
773
1.07
0.20
2.7
2.9
ug/l
0.8
0.8
0.23
53
485
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
1.2
—
0
9
(3005011) Chlamydia sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
196
0.86
0.19
1.4
1.8
mg/l
2.7
3.6
—
9
145
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
65
610
1.07
0.18
3.5
2.2
%
20.8
22.9
0.70
54
534
(44790048)
7
60
1.17
0.18
1.6
1.6
—
—
—
0
0
(44790049)
7
60
1.17
0.18
1.6
1.6
—
—
—
0
0
(44806118)
7
60
1.17
0.18
1.6
1.6
—
—
—
0
0
(44790047)
7
60
1.17
0.18
1.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
91
1.21
0.17
4.1
3.6
%
60.6
56.5
0.52
11
91
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
205
1.13
0.17
1.1
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
63
1.11
0.17
1.9
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
63
1.11
0.17
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
148
1.15
0.17
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
83
1.21
0.15
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
83
1.21
0.15
1.1
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
79
1.14
0.15
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
80
1.13
0.15
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
80
1.13
0.15
1.4
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
93
1.19
0.14
1.4
1.7
—
—
—
0
0
(4034850)
17
150
1.14
0.14
8.5
9.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
150
1.14
0.14
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
13
112
1.16
0.14
2.2
1.9
pmol/l
177.4
230.3
0.79
13
103
(3002385) Erythrocyte distribution width [Ratio]
416
4113
1.04
0.14
20.7
15.7
%
13.6
13.6
0.24
416
4036
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
412
1.07
0.14
3.4
4.4
ug/l
4.6
35.5
0.93
35
334
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
122
1.15
0.14
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
1170
1.04
0.13
1.5
1.3
u/ml
1.0
2.1
0.96
28
311
(3020682) Albumin/Creatinine [Ratio] in Urine
137
1329
1.04
0.13
4.1
4.1
mg/mmol
6.5
9.7
0.51
93
853
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
304
0.92
0.13
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
114
1.14
0.12
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
454
4504
1.04
0.11
19.9
13.7
%
39.4
40.2
1.22
320
3416
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
115
1.13
0.10
1.2
1.2
u/ml
0.1
3.1
—
5
52
(3017181) Myelocytes/100 leukocytes in Blood
41
388
1.06
0.10
4.3
4.6
%
0.5
0.8
1.14
13
117
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
271
1.07
0.10
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
44
1.14
0.10
1.6
2.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
46
1.09
0.09
1.2
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
56
1.07
0.08
6.2
2.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
64
0.78
0.08
3.6
2.4
mmol/l
3.7
4.0
—
5
64
(3035285) Chloride [Moles/volume] in Venous blood
5
64
0.78
0.08
3.6
2.4
mmol/l
105.6
105.7
—
5
64
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
64
0.78
0.08
3.6
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
106
1034
1.03
0.08
1.5
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
79
814
0.97
0.08
1.3
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
117
1.11
0.08
1.4
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
65
1.08
0.08
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
65
1.08
0.08
1.0
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
98
1.12
0.07
1.0
1.1
u/ml
0.1
0.8
—
5
50
(3025159) Blasts/100 leukocytes in Blood
36
343
1.05
0.07
4.6
4.9
%
0.0
0.1
0.66
11
88
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
163
0.92
0.07
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
122
0.90
0.07
7.8
4.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
88
1.02
0.07
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
464
4663
0.98
0.06
4.5
4.2
mmol/l
4.7
4.7
0.38
439
4336
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
123
1252
0.98
0.06
1.7
1.7
mmol/l
1.5
1.4
0.41
109
1062
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
426
4283
0.98
0.06
5.9
5.5
mmol/mol
38.3
39.5
2.50
395
3994
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
168
1.07
0.06
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
90
1.11
0.05
2.3
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
139
1.08
0.05
1.5
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
130
0.92
0.04
1.6
1.4
ug/g
300.3
310.4
—
7
71
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
140
1.07
0.04
2.6
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
59
603
0.98
0.04
1.4
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
102
1.08
0.03
1.0
1.1
u/ml
1.1
5.1
—
6
60
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
447
4483
0.99
0.02
4.0
3.8
mmol/l
1.2
1.3
0.60
417
4137
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
659
1.02
0.02
3.3
2.2
g/l
2.3
2.4
0.19
59
611
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
279
0.97
0.02
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
449
0.98
0.02
4.2
3.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
104
1050
0.99
0.02
1.6
1.5
g/l
2.4
2.3
0.04
60
657
(4094501)
12
113
1.06
0.02
1.5
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
163
1.04
0.01
3.1
2.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
463
4637
0.99
0.01
4.5
4.1
mmol/l
1.5
1.5
0.59
433
4289
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
164
1.04
0.00
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
204
1.03
0.00
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
23
225
1.02
0.00
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
144
0.97
0.00
1.2
1.1
—
11.7
—
0
17
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
525
0.99
0.00
3.2
2.8
umol/l
8.6
8.3
0.03
40
462
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
474
4737
1.00
0.00
5.0
4.6
mmol/l
2.8
2.8
0.01
442
4383
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
121
0.99
0.00
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
52
522
1.00
0.00
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
62
618
1.00
0.00
2.8
2.4
ug/g
104.0
124.1
0.32
46
481
(3037121) Protein [Mass/volume] in Urine
17
169
1.01
0.00
2.3
3.8
g/l
0.3
0.2
—
8
74
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.8
—
1.2
—
0
8
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.0
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
93
0.97
0.00
9.4
5.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
34.6
—
0
5
(44806071)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
16.6
—
0
7
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
77
0.91
0.00
1.4
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
130
1.00
0.00
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
68
0.88
0.00
1.3
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.8
—
0
8
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
18.1
—
0
6
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
170.3
—
0
8
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
51
0.98
0.00
1.0
7.6
mmol/l
6.0
6.7
—
5
42
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
65
0.92
0.00
1.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3022229) Phosphate [Moles/volume] in Urine
0
7
0.00
0.00
0.0
3.0
—
18.1
—
0
7
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BRAIN_SUPRATENT and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_BRAIN_SUPRATENT 1.794 [1.53, 2.1] < 0.001
Birth year 1.003 [1.0, 1.01] 0.441

During the follow-up period (1.1.1998 — 31.12.2019), 355 out of 1970 females with CD2_BENIGN_BRAIN_SUPRATENT died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_BRAIN_SUPRATENT 2.162 [1.81, 2.59] < 0.001
Birth year 0.992 [0.98, 1.0] 0.09

During the follow-up period (1.1.1998 — 31.12.2019), 363 out of 1653 males with CD2_BENIGN_BRAIN_SUPRATENT died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BRAIN_SUPRATENT.

N-year risk Females Males
1 0.206% 0.378%
5 1.309% 2.719%
10 2.936% 7.058%
15 5.921% 13.53%
20 11.166% 22.667%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT – Benign neoplasm: Brain, supratentorial

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data